Profile
NVOS HCA FMS DVA THC UHS
Company Name Novo Integrated Sciences, Inc. HCA Healthcare, Inc. Fresenius Medical Care AG & Co. KGaA DaVita Inc. Tenet Healthcare Corporation Universal Health Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities
Market Cap $9.97M $81.40B $12.31B $11.79B $11.75B $10.06B
Employees 0.13K 220.00K 119.85K 70.00K 78.81K 96.70K
CEO Mr. Robert Mattacchione Mr. Samuel N. Hazen Ms. Helen Giza Mr. Javier J. Rodriguez Dr. Saumya Sutaria M.D. Mr. Marc D. Miller
Ratings
NVOS HCA FMS DVA THC UHS
Quant Rating Score 2 2 4 5 5 4
Quant Rating Sell Sell Buy Strong Buy Strong Buy Buy
Trading
NVOS HCA FMS DVA THC UHS
Last Close $0.523 $307.76 $20.97 $134.45 $120.28 $167.7
High 52 $1.77 $333.53 $27.56 $142.24 $120.28 $182.46
Low 52 $0.07 $221.75 $16.39 $73.2 $52.66 $122.21
Price vs. 52 Week High -70.45 % -7.73 % -23.91 % -5.48 % 0 % -8.09 %
Price vs. 52 Week Low 647.14 % 38.79 % 27.94 % 83.67 % 128.41 % 37.22 %
Total Return
NVOS HCA FMS DVA THC UHS
1 Month Return 16.48 % -6.4 % 11.84 % 0.63 % 17.71 % -3.3 %
3 Month Return -34 % -0.92 % 8.09 % 21.41 % 33.59 % 3.09 %
6 Month Return 75.5 % 33.32 % 20.31 % 69.23 % 119.01 % 30.76 %
9 Month Return 397.62 % 14.54 % -18.88 % 23.56 % 61.49 % 24.81 %
YTD Return -36.3 % 13.7 % 0.67 % 28.34 % 59.16 % 10.01 %
1 Year Return 210.39 % 10.71 % -10.46 % 51.97 % 73.44 % 17.44 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NVOS HCA FMS DVA THC UHS
Dividend Yield Percentage (TTM) - 0.8 % 3.43 % - - 0.48 %
Dividend Paid and Capex Coverage Ration (TTM) -100.61 % 1.89 % 3.84 % 2.7 % 3.28 % 1.64 %
Dividend Per Share (TTM) - 2.46 % 0.67 % - - 0.8 %
Payout Ratio (TTM) - 12.27 % - - - 6.72 %
Growth
NVOS HCA FMS DVA THC UHS
Asset Growth -12.99 % 7.2 % -5.1 % 4.08 % 4.26 % 6.39 %
Gross Profit Growth 3.2 % 8.27 % -7.25 % -9.57 % -84.74 % -90.14 %
Revenue Growth 7.11 % 7.86 % 0.29 % 4.57 % 7.17 % 6.59 %
Revenue 3 Year -63.76 % 56.56 % 9.17 % 38.68 % 20.35 % 51.61 %
Revenue 5 Year -71.14 % 75.2 % 145.66 % 100.24 % 12.72 % 78.4 %
Revenue 10 Year - 206.73 % 280.78 % 138.63 % 85.1 % 177.29 %
EBIT Growth 65.82 % 5.81 % 679.42 % 19.56 % 4.03 % 17.12 %
Net Income Growth 59.77 % -7.11 % -25.9 % -9.98 % -38.9 % 6.24 %
Net Income 3 Yeari Growth Per Share 39.08 % 73.4 % -57.05 % 17.95 % -17.8 % -6.69 %
Net Income 5 Yeari Growth Per Share -28 % 74.24 % -47.39 % 64.65 % 453 % 23.87 %
Net Income 10 Yeari Growth Per Share 88.66 % 443.67 % 28.57 % 152.44 % 556.01 % 98.75 %
Operating Income Growth 65.82 % 5.81 % 679.42 % 19.56 % 4.03 % 17.12 %
Operating Cash Flow Growth (CFG) 61.88 % 10.67 % 21.31 % 31.92 % 119.21 % 27.29 %
Operating 3 Year CFG -15.08 % 26.86 % -37.76 % 37.61 % -28.01 % -34.09 %
Operating 5 Year CFG 50.98 % 75.59 % 166.38 % 119.15 % 127.36 % 27.22 %
Operating 10 Year CFG 93.14 % 313.58 % 269.44 % 169.13 % 303.09 % 102.76 %
EPS Growth 88.48 % -1.03 % -26.09 % -7.75 % -35.72 % 12.13 %
EPS Diluted Growth 88.48 % -0.99 % -26.09 % -7.48 % -35.58 % 11.93 %
Book Value Per Share -68.13 % 31.66 % -11.89 % 51.86 % 48.13 % 9.55 %
Share Holder 3 Year Equity Growth Per Share -81.02 % -485.13 % 10.7 % 0.72 % 5833.33 % 19.44 %
Share Holder 5 Year Equity Growth Per Share 2416.07 % 54.89 % 120.58 % -46.36 % 1457.52 % 53.53 %
Share Holder 10 Year Equity Growth Per Share 119.95 % 65.38 % 321.78 % -44.9 % 113 % 167.57 %
Dividend Per Share Growth - 7.89 % -16.97 % - - 0.12 %
Dividend 3 Year Growth Per Share - 436.49 % -6.22 % - - 292.51 %
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 6566.99 % 217.34 % - - 299.87 %
Debt Growth -65.59 % 5.08 % -8.8 % -5.97 % 7.52 % 1.81 %
Free Cash Flow Growth 62.26 % 13.57 % 157.17 % 55.64 % 405.61 % 100.27 %
Updated On 31 Aug 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
NVOS HCA FMS DVA THC UHS
Gross Profit Margin TTM 40.35 % 66.64 % 25.32 % 30.82 % 47.18 % 48.25 %
Return on Assets TTM -34.58 % 9.6 % 1.61 % 4.68 % 9.06 % 5.81 %
Return on Equity TTM -49.75 % -267.84 % 3.98 % 77.7 % 133.15 % 13.3 %
Return on Capital Employed TTM -37.54 % 22.28 % 4.96 % 12.09 % 11.28 % 10.72 %
Net Income Per EBT TTM 99.92 % 68.11 % 54.11 % 61.13 % 60.61 % 76.17 %
EBT Per Ebit TTM 128.91 % 82.24 % 73.14 % 74.3 % 163.06 % 83.52 %
EBIT Per Revenue TTM -68.69 % 14.64 % 7.1 % 14.55 % 12.68 % 8.76 %
Cash Flow To Debt Ratio TTM -92.71 % 25.12 % 21.82 % 12.36 % 19.5 % 27.84 %
Receivables Turnover TTM 6.34 6.64 4.79 4.12 6.64 6.37
Payables Turnover TTM 3.75 4.7 16.41 17.42 8.27 4.15
Inventory Turnover TTM 8.6 11.7 6.67 58.54 27.94 35.11
Fixed Asset Turnover TTM 190.67 % 220.13 % 260.98 % 223.79 % 356.87 % 221.86 %
Asset Turnover TTM 39.08 % 117.12 % 57.34 % 70.78 % 72.28 % 104.36 %
Operating Cash Flow Per Share TTM -0.28 38.36 8.96 16.67 25.22 20.44
Free Cash Flow Per Share TTM -0.28 20.64 6.63 10.5 17.52 8.79
Cash Per Share TTM 3.69 % 523.9 % 524.78 % 405.29 % 2491.44 % 166.8 %
Operating Cash Flow Sales Ratio TTM -36.26 % 15.13 % 13.51 % 11.86 % 12.02 % 9.37 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.99 % 53.8 % 73.96 % 63.01 % 69.49 % 43 %
Cash Flow Coverage Ratios TTM -92.71 % 25.12 % 21.82 % 12.36 % 19.5 % 27.84 %
Price To Free Cash Flows Ratio TTM -1.99 14.98 5.88 12.79 6.73 17.03
Price To Operating Cash Flows Ratio TTM -1.86 8.02 2.17 8.07 4.77 8.21
Price Cash Flow Ratio TTM -1.86 8.02 2.17 8.07 4.77 8.21
Income Statement (TTM)
NVOS HCA FMS DVA THC UHS
Revenue $0.01B $64.97B $19.45B $12.14B $20.55B $14.28B
Gross Profit $0B $55.07B $4.93B $3.07B $2.43B $1.18B
Gross Profit Ratio 39.39% 84.76% 25.32% 25.33% 11.81% 8.23%
EBITDA $-0.01B $12.73B $3.44B $2.35B $3.3B $1.74B
Net Income $-0.01B $5.24B $0.5B $0.69B $0.61B $0.72B
EPS Diluted -1.3 18.96 1.7 7.42 5.83 10.23
Balance Sheet (MRQ)
NVOS HCA FMS DVA THC UHS
Long Term Debt $0B $36.63B $10.49B $8.05B $14.76B $4.72B
Total Liabilities $0.01B $55.15B $19.1B $14.88B $22.8B $8.15B
Total Equity $0.02B $1.06B $14.83B $2.74B $5.51B $6.2B
Total Investments $0B $1.35B $1.39B $0.61B $1.89B $0.31B
Total Debt $0B $41.86B $12.05B $11.12B $16.21B $5.37B
Total Assets $0.04B $56.21B $33.93B $17.62B $28.31B $14.36B
Cash Flow Statement (TTM)
NVOS HCA FMS DVA THC UHS
Net Income $-0.01B $5.24B $0.5B $0.69B $0.61B $0.72B
Inventory $-0B $-0.13B $-0.01B $-0.03B $-0.14B $0B
Dividends Paid $0B $-0.66B $-0.33B $0B $0B $-0.06B
Operating Cash Flow $-0B $9.43B $2.63B $2.06B $2.37B $1.27B
Capital Expenditure $-0B $-4.74B $-0.68B $-0.57B $-0.75B $-0.74B
Related Stocks
Ticker Name Price
ACHC Acadia Healthcare Company, Inc. 66.12
ADUS Addus HomeCare Corporation 98.2
AGL agilon health, inc. 4.83
AIH Aesthetic Medical International Holdings Group Limited 0.41
AIRS AirSculpt Technologies, Inc. 5.465
ALR AlerisLife Inc. 1.32
AMED Amedisys, Inc. 92.08
AMEH Apollo Medical Holdings, Inc. 40.82
AMN AMN Healthcare Services, Inc. 59.53
AMS American Shared Hospital Services 2.97
AONC American Oncology Network, Inc. 3.74
ASTH Astrana Health, Inc. 37.46
ATIP ATI Physical Therapy, Inc. 4.6299
AUNA 6.49
AVAH Aveanna Healthcare Holdings Inc. 2.33
BACK IMAC Holdings, Inc. 3.7
BKD Brookdale Senior Living Inc. 7.49
BKDT Brookdale Senior Living Inc. 7. 101.87
BTMD Haymaker Acquisition Corp. III 6.01
BTMDW Haymaker Acquisition Corp. III 1.61
ETFs With Exposure to NVOS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 253.53
VXF Vanguard Extended Market Index Fund 0 168.48
IWC iShares Micro-Cap ETF 0 116.72
VTSAX Vanguard Total Stock Market Index Fund 0 123.37
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 127.82
VITSX Vanguard Total Stock Market Index Fund 0 123.39
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 127.82
VEMPX Vanguard Extended Market Index InstlPlus 0 315.43
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 231.45
Unlock